ArticleJTCVS open2025
Achieving and maintaining superior postoperative outcomes with an optimized recovery after thoracic surgery protocol.
Article in JTCVS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Protocol optimization to improve postoperative outcomes is a key component of enhanced recovery after surgery program. The aim of this study is to determine the long-term impact of protocol optimization on postoperative outcomes of robotic pulmonary anatomic resections. Methods: A retrospective analysis of a prospectively maintained database was performed. All elective robotic anatomic pulmonary resections between February 1, 2018, and December 31, 2023, were included and stratified into original Enhanced Recovery After Thoracic Surgery (ERATS) - group A (February 1, 2018, to December 31, 2019, n = 184) and optimized ERATS - group B (January 1, 2020, to December 31, 2023, n = 557). Propensity-score matching yielded highly comparable cohorts for outcome analysis. Data included demographics, operative details, postoperative outcomes (hospital length of stay [LOS], postoperative opioid use, 30-day complications), patient-reported subjective pain, and cost-savings resulting from reducing observed LOS versus expected LOS on the basis of Medicare Severity Diagnosis-Related Group classification and estimated institution per-diem cost of $1100.00. Results: Of the 732 eligible patients, 499 were matched with 173 to group A and 326 group B. Protocol optimization was associated with significant improvement of postoperative outcomes: shorter LOS, greater percentages of postoperative day 1 discharge, substantial less opioid requirements with increasing number of opioid-free postdischarges, and greater cost-savings either collectively or per individual DRGs attributable to the reduction of LOS. Annual auditing of the optimized ERATS cohort demonstrated consistent improvements in key metrics over time. Conclusions: Successful ERATS protocol optimization and maintenance was associated with durable and significantly superior postoperative outcomes along with greater cost-savings attributable to a reduction of LOS in patients undergoing elective robotic pulmonary anatomic resections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.